Rhein attenuates severe acute pancreatitis-associated intestinal injury through pparγ regulating macrophage activation
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Jun-2026 10:16 ET (15-Jun-2026 14:16 GMT/UTC)
A Chinese Medical Journal study reveals Rhein, a rhubarb-derived compound, protects against severe acute pancreatitis-associated intestinal injury by activating peroxisome proliferator-activated receptor γ (PPARγ) to suppress NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome and reprogram macrophage polarization from pro-inflammatory M1 to anti-inflammatory M2 phenotype. Rhein restored intestinal barrier integrity and reduced endotoxemia—effects abolished by PPARγ inhibition. This identifies the PPARγ/NLRP3/macrophage axis as a promising therapeutic target for SAP complications.
The biological shifts that accompany aging seemingly occur in many cells in the body, but technical limitations have stymied our understanding of those changes. Now researchers have produced two groundbreaking techniques that overcome these traditional barriers. The researchers hope their techniques will function as both clinical and research tools for diagnosing disease and uncovering new biology across a wide range of conditions.
A new worm model developed by Brown University researchers could play a key role in treating a rare genetic disease that causes paralysis in children and worsens with age. Developed in the lab of neuroscientist Anne Hart, a genetically engineered C. elegans nematode model provides a fast, inexpensive way to evaluate potential drug treatments for alternating hemiplegia of childhood, or AHC, a disorder that currently has no cure or effective treatments.
For decades, scientists have known that estrogen protects cardiovascular health, but exactly how that protection works—and what happens when it disappears—has remained unclear. New research from University of Texas at Arlington points to the liver and the immune system as critical players.